Currently, Elizabeth Barrett is President, Chief Executive Officer & Director at UroGen Pharma Ltd.

She is also on the board of SAGE Therapeutics, Inc. and Allogene Therapeutics, Inc.

In her past career Ms. Barrett was General Manager-Oncology Business Unit at Johnson & Johnson Vice President-Critical Care & Surgery Franchise at Ortho Biotech, Inc. and Vice President-Sales & Marketing of Veridex LLC (both are subsidiaries of Johnson & Johnson), Global President & General Manager-Oncology at Pfizer Inc. and Chief Executive Officer at Medivation LLC (California) (a subsidiary of Pfizer Inc.), Chief Executive Officer of Novartis Oncology, Inc. and Vice President & GM-Oncology Business Unit at Cephalon, Inc.

Ms. Barrett received an MBA from St. Joseph's University and an undergraduate degree from the University of Louisiana at Lafayette.